ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF

DEFINITIVE CONTRACT won by NOVARTIS PHARMACEUTICALS CORPORATION · work in EAST HANOVER, NJ
$16,334,775
RecipientNOVARTIS PHARMACEUTICALS CORPORATION UEI NG61ZA8TADW3
Award IDHHSO100201700026C
Award amount$16,334,775
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
PSCAN92
Set-asideUnrestricted
Start dateSep 14, 2017
End dateMay 22, 2026
Place of performanceEAST HANOVER, NJ
Record updatedJul 8, 2026

View the official award record

More awards won by NOVARTIS PHARMACEUTICALS CORPORATION

CLIN 2001AA AND CLIN 2001AB
Department of Defense · $5,369,485 · Oct 1, 2026
PLUVICTO
Department of Veterans Affairs · $4,732,608 · Feb 24, 2026
PLUVICTO AND LUTATHERA
Department of Veterans Affairs · $4,299,447 · Nov 1, 2025
LU177 - PLUVICTO/LUTATHERA
Department of Veterans Affairs · $4,162,659 · Feb 7, 2026
PLUVICTO NDC: 69488-0010-61
Department of Veterans Affairs · $4,115,311 · Oct 1, 2026

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids